Enovix (NASDAQ:ENVX) Shares Climb 5.3% - Here's What Happened

Key Points

• Enovix shares rose 5.3% to approximately $2.70 in midday trading, though volume was 87% below the average session level.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $11.77, despite ratings ranging from Sell to Strong Buy.
• Enovix beat quarterly expectations, reporting a $0.13 per-share loss versus the anticipated $0.15 loss and $9.02 million in revenue, up 20.8% year over year; institutional investors own 50.92% of the stock.

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s stock price shot up 5.3% during mid-day trading on Tuesday. The stock traded as high as $2.68 and last traded at $2.6950. Approximately 871,017 shares were traded during trading, a decline of 87% from the average session volume of 6,652,274 shares. The stock had previously closed at $2.56.

Analysts Set New Price Targets

Several research firms recently issued reports on ENVX. Craig Hallum set a $7.00 price target on shares of Enovix in a research report on Thursday, August 13th. Wall Street Zen upgraded Enovix from a "strong sell" rating to a "sell" rating in a research note on Saturday, September 12th. Bank of America reaffirmed a "neutral" rating and set a $5.00 target price on shares of Enovix in a research report on Monday, August 17th. Cantor Fitzgerald reiterated an "overweight" rating and set a $25.00 target price on shares of Enovix in a research note on Thursday, August 13th. Finally, Loop Capital raised shares of Enovix to a "strong-buy" rating in a report on Monday, August 17th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $11.77.

Enovix Price Performance

The stock has a market cap of $598.00 million, a PE ratio of -3.36 and a beta of 2.31. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The firm's 50 day moving average price is $3.64 and its two-hundred day moving average price is $5.25.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The firm had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same period in the prior year, the firm posted ($0.13) earnings per share. The company's revenue for the quarter was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. On average, research analysts expect that Enovix Corporation will post -0.8 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Enovix during the 2nd quarter valued at about $100,054,000. Granahan Investment Management LLC grew its holdings in shares of Enovix by 12.3% during the fourth quarter. Granahan Investment Management LLC now owns 1,964,565 shares of the company's stock worth $14,361,000 after purchasing an additional 214,916 shares in the last quarter. CenterBook Partners LP increased its position in shares of Enovix by 66.1% in the fourth quarter. CenterBook Partners LP now owns 1,757,382 shares of the company's stock worth $12,846,000 after purchasing an additional 699,519 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Enovix in the second quarter worth approximately $8,689,000. Finally, Bank of America Corp DE purchased a new stake in Enovix in the second quarter valued at approximately $8,356,000. Institutional investors own 50.92% of the company's stock.

Enovix Company Profile

Enovix Corporation NASDAQ: ENVX is a battery technology company developing lithium-ion batteries with silicon-anode materials and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while maintaining safety and durability for applications that require compact, high-performance energy storage.

The company's battery platform incorporates a silicon anode, a stainless-steel constraint system and its BrakeFlow technology, which is designed to help prevent thermal runaway from spreading within a battery pack.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.